ecoli-uk.com

E.coli O157 & Haemolytic Uraemic Syndrome


This may be a better way to treat patients with Shiga toxin producing Escherichia coli (STEC) initially to help prevent developing Haemolytic uremic syndrome (HUS)?

18th March 2026

A University of Calgary research team found that only 7% of children infected at child care centres with STEC, developed HUS (of which more than half of whom required dialysis). 

During this outbreak, there were 395 cases, linking food consumption at 11 childcare centres to a shared kitchen in Alberta Canada, perhaps partly due to daily lab monitoring for kidney injury. Links below to this research.

“The study identified significant use of health care resources, the researchers said. Only 7% of children infected with STEC developed HUS, which is lower than reported in most prior outbreaks and sporadic case series, they wrote. These findings highlight the importance of a coordinated public health response integrated with clinical care and suggest that proactive screening for Thrombotic microangiopathy (TMA) has the potential to mitigate adverse outcomes.”

It also stated HUS occurs in 15% to 20% of children infected by STEC carrying a gene encoding Shiga toxin 2 (stx2), which is termed high-risk STEC”. The stx 2 gene encoding has been mentioned previously by many scientists throughout the world in terms of its risk.

In the UK our National Health Service in coordination with the UK Health Security Agency (UKHSA) should at least give a trial of daily lab monitoring for kidney injury to all patients of STEC including screening for Thrombotic microangiopathy (TMA). This could be undertaken during an outbreak anywhere in the UK or across the UK to ascertain if this is effective in reducing the cases that progress to HUS.

Presently there is no cure for Haemolytic uremic syndrome (HUS) caused by Shiga toxin producing Escherichia coli (STEC) and we already know that approximately 30% of those who suffer from HUS in the UK will have some long term health problems which may be major or minor.  

  

Whilst such a trial, I believe, could be beneficial, I cannot see it being undertaken in the UK due to the additional patient clinical care required at a time when our NHS service is struggling to cope with the demands being placed on it.  

https://www.cidrap.umn.edu/e-coli/early-detection-kidney-injury-e-coli-outbreak-daycare-centers-may-have-improved-outcomes

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2846153

 

 




Page
1 of 51
Next > Last >>

18th March 2026

A University of Calgary research team found that only 7% of children infected at child care centres with STEC, deve... ...read on
18th January 2026

From research into the UK Health Security Agency (UKHSA) weekly reports for NOID’s (Notifiable diseases) causative agents (often referred to as NOID’s Notification of infectious diseases), up to week 52 ending 28... ...read on
18th November 2025

The number of cases, according to the UK Health Security Agency (UKHSA) weekly Notifiable diseases: causative agents reports for 2025 (often referred to as NOID’s Notification of infectious diseases... ...read on
12th August 2025

The UK Health Security Agency (UKHSA) published the Shiga toxin-producing Escherichia coli (STEC) data in England during 2024 on 30... ...read on
29th June 2025

According to the UK Health Security Agency (UKHSA) data published on the 26th June 2025 for the year 2024 in the Link below, Cases of Salmonella and Campylobacter are the highest in a decade. ... ...read on
Page
1 of 51
Next > Last >>

Designed by Robert Woods. View our Cookie & Privacy Policy